Evidence map›Paper›PMID 26370849›Full record

ArticleBMC veterinary research2015

Saliva as an alternative specimen for detection of Schmallenberg virus-specific antibodies in bovines.

Justas Lazutka, Aliona Spakova, Vilimas Sereika, Raimundas Lelesius, Kestutis Sasnauskas, Rasa Petraityte-Burneikiene

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Evaluation of P22 ELISA for the Detection ofFrontiers in veterinary science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Justas LazutkaInstitute of Biotechnology, Vilnius University, V. A. Graiciuno 8, 02241, Vilnius, Lithuania. justas.lazutka@bti.vu.lt.
Aliona SpakovaInstitute of Biotechnology, Vilnius University, V. A. Graiciuno 8, 02241, Vilnius, Lithuania. aliona.spakova@gf.stud.vu.lt.
Vilimas SereikaInstitute of Microbiology and Virology, Veterinary Academy, Lithuanian University of Health Sciences, Tilzes 18, 47181, Kaunas, Lithuania. sereika@lva.lt.
Raimundas LelesiusInstitute of Microbiology and Virology, Veterinary Academy, Lithuanian University of Health Sciences, Tilzes 18, 47181, Kaunas, Lithuania. lelesius@lva.lt.
Kestutis SasnauskasInstitute of Biotechnology, Vilnius University, V. A. Graiciuno 8, 02241, Vilnius, Lithuania. kestutis.sasnauskas@bti.vu.lt.
Rasa Petraityte-BurneikieneInstitute of Biotechnology, Vilnius University, V. A. Graiciuno 8, 02241, Vilnius, Lithuania. rasa.burneikiene@bti.vu.lt.
Vilnius University · LTLithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchmallenberg virus (SBV), discovered in continental Europe in late 2011, causes mild clinical signs in adult ruminants, including diarrhoea and reduced milk yield. However, fetal infection can lead to severe malformation in newborn offspring. Enzyme-linked immunosorbent assays (ELISA) are commercially available for detection of SBV-specific antibodies in bovine sera and milk. Here we describe the development and evaluation of an indirect ELISA based on a yeast derived recombinant SBV nucleocapsid protein (N) for the detection of SBV-specific antibodies in bovine saliva. Development of a non-invasive test to detect antibodies in individual bovine saliva samples could potentially provide a test suitable for calves and adult cattle. The aim of this study was to investigate the agreement between the levels of antibodies (IgG) measured in milk and sera, and the level of antibodies (IgG and IgA) in saliva, in comparison with the antibody levels detected in sera and milk with commercially available test.

resultsSerum, milk and saliva samples from 58 cows were collected from three dairy herds in Lithuania and tested for the presence of SBV-specific antibodies. The presence of IgG antibodies was tested in parallel serum and milk samples, while the presence of IgA and IgG antibodies was tested in saliva samples. The presence of SBV-specific IgG and IgA in saliva was tested using an indirect ELISA based on a yeast-derived recombinant N protein. The presence of SBV-specific IgG in milk and sera was tested in parallel using a commercial recombinant protein based test. The sensitivities of the newly developed tests were as follows: 96 % for the IgG serum assay and 94 % for the IgG milk assay and 85 % and 98 % for IgG and IgA in saliva tests, when compared with data generated by a commercial IgG assay.

conclusionsData from testing the saliva IgG and IgA and also the milk and serum IgG with indirect SBV-specific ELISAs showed close agreement with the commercial serum and milk IgG assay data. The level of IgG in saliva was notably lower in comparison to IgA. The newly developed method exhibits the potential to serve as an easily transferable tool for epidemiological studies.

Indexed as

AnimalsAntibodies, ViralBunyaviridae InfectionsCattleCattle DiseasesEnzyme-Linked Immunosorbent AssayImmunoglobulin AImmunoglobulin GOrthobunyavirusSalivaAntibodies, ViralImmunoglobulin AImmunoglobulin G

Identifiers

PMID26370849
PMCPMC4570040
OpenAlexW1834400826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.